Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID-19: Protocol and methodology of a prospective longitudinal observational study.
Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID-19: Protocol and methodology of a prospective longitudinal observational study.
复制标题
DOI:
10.1371/journal.pone.0289508
复制
发表时间:
2023
期刊:
影响因子:
3.7
通讯作者:
中科院分区:
文献类型:
--
作者:
Mild cognitive impairment (MCI) is a prodromal stage to dementia, affecting up to 20% of the aging population worldwide. Patients with MCI have an annual conversion rate to dementia of 15–20%. Thus, conditions that increase the conversion from MCI to dementia are of the utmost public health concern. The COVID-19 pandemic poses a significant impact on our aging population with cognitive decline as one of the leading complications following recovery from acute infection. Recent findings suggest that COVID-19 increases the conversion rate from MCI to dementia in older adults. Hence, we aim to uncover a mechanism for COVID-19 induced cognitive impairment and progression to dementia to pave the way for future therapeutic targets that may mitigate COVID-19 induced cognitive decline. A prospective longitudinal study is conducted at the University of Oklahoma Health Sciences Center. Patients are screened in the Department of Neurology and must have a formal diagnosis of MCI, and MRI imaging prior to study enrollment. Patients who meet the inclusion criteria are enrolled and followed-up at 18-months after their first visit. Visit one and 18-month follow-up will include an integrated and cohesive battery of vascular and cognitive measurements, including peripheral endothelial function (flow-mediated dilation, laser speckle contrast imaging), retinal and cerebrovascular hemodynamics (dynamic vessel retinal analysis, functional near-infrared spectroscopy), and fluid and crystalized intelligence (NIH-Toolbox, n-back). Multiple logistic regression will be used for primary longitudinal data analysis to determine whether COVID-19 related impairment in neurovascular coupling and increases in white matter hyperintensity burden contribute to progression to dementia.
登录
查看更多内容
DOI:
10.1038/s41579-022-00846-2
发表时间:
2023-03
期刊:
Nature reviews. Microbiology
影响因子:
--
作者:
通讯作者:
--
影响因子:
6.7
作者:
Cheng ST
通讯作者:
Cheng ST
DOI:
10.1016/j.jstrokecerebrovasdis.2022.106333
发表时间:
2022-02-11
影响因子:
2.5
作者:
Andere, Ariana;Jindal, Gaurav;Cutting, Shawna
通讯作者:
Cutting, Shawna
影响因子:
5.6
作者:
Csiszar, Anna;Yabluchanskiy, Andriy;Tarantini, Stefano
通讯作者:
Tarantini, Stefano
影响因子:
11
作者:
Al-Hakeim, Hussein Kadhem;Al-Rubaye, Haneen Tahseen;Al-Hadrawi, Dhurgham Shihab;Almulla, Abbas F.;Maes, Michael
通讯作者:
Maes, Michael